CRVS - CIK 0001626971
Corvus Pharmaceuticals, Inc. has filed 570 documents with the SEC between 2014 and 2026. The most frequent type is insider trade (219 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2024-05-06 | 2024-05-01 |
| Major company event | 8-K | 2024-05-06 | 2024-05-06 |
| Prospectus supplement | 424B5 | 2024-05-03 | - |
| Major company event | 8-K | 2024-05-01 | 2024-05-01 |
| Proxy materials | DEFA14A | 2024-04-26 | - |
| Proxy statement | DEF 14A | 2024-04-26 | 2024-06-13 |
| Annual report | 10-K | 2024-03-19 | 2023-12-31 |
| Major company event | 8-K | 2024-03-19 | 2024-03-19 |
| Insider trade | 4 | 2024-03-01 | 2024-02-28 |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| New insider ownership | 3 | 2024-02-08 | 2024-02-02 |
| Major company event | 8-K | 2024-01-23 | 2024-01-23 |
| Insider trade | 4 | 2023-12-08 | 2023-12-06 |
| Insider trade | 4 | 2023-12-08 | 2023-12-06 |
| Insider trade | 4 | 2023-12-08 | 2023-12-06 |
| Insider trade | 4 | 2023-12-08 | 2023-12-06 |
| Insider trade | 4 | 2023-12-08 | 2023-12-06 |
| Insider trade | 4 | 2023-12-08 | 2023-12-06 |
| Insider trade | 4 | 2023-12-08 | 2023-12-06 |
| Insider trade | 4 | 2023-12-08 | 2023-12-06 |
| Insider trade | 4 | 2023-12-08 | 2023-12-06 |
| Quarterly report | 10-Q | 2023-11-07 | 2023-09-30 |
| Major company event | 8-K | 2023-11-07 | 2023-11-07 |
| Major company event | 8-K | 2023-09-07 | 2023-09-06 |
| Quarterly report | 10-Q | 2023-08-08 | 2023-06-30 |
| Major company event | 8-K | 2023-08-08 | 2023-08-08 |
| Major company event | 8-K | 2023-06-21 | 2023-06-15 |
| Insider trade | 4 | 2023-06-20 | 2023-06-15 |
| Insider trade | 4 | 2023-06-20 | 2023-06-15 |
| Insider trade | 4 | 2023-06-20 | 2023-06-15 |
| Insider trade | 4 | 2023-06-20 | 2023-06-15 |
| Insider trade | 4 | 2023-06-20 | 2023-06-15 |
| Insider trade | 4 | 2023-06-20 | 2023-06-15 |
| Insider trade | 4 | 2023-05-16 | 2023-05-15 |
| EFFECT | - | 2023-05-08 | - |
| Quarterly report | 10-Q | 2023-05-08 | 2023-03-31 |
| Major company event | 8-K | 2023-05-08 | 2023-05-08 |
| Company correspondence | CORRESP | 2023-05-04 | - |
| Proxy materials | DEFA14A | 2023-04-28 | - |
| Proxy statement | DEF 14A | 2023-04-28 | 2023-06-15 |
| Major company event | 8-K | 2023-04-24 | 2023-04-21 |
| Major company event | 8-K | 2023-04-03 | 2023-03-29 |
| Insider trade | 4 | 2023-04-03 | 2023-03-31 |
| SEC correspondence | UPLOAD | 2023-03-31 | - |
| Major company event | 8-K | 2023-03-29 | 2023-03-28 |
| Securities registration | S-3 | 2023-03-29 | - |
| Annual report | 10-K | 2023-03-28 | 2022-12-31 |
| Employee stock plan | S-8 | 2023-03-28 | - |
| Major company event | 8-K | 2023-03-28 | 2023-03-28 |